C-reactive protein (CRP) is one of the most ordered blood tests in medicine — a non-specific but highly sensitive marker of inflammation that rises rapidly in response to infection, autoimmune activity, tissue injury, and chronic disease. For clinicians, understanding what CRP levels mean and which assay type to order (standard CRP vs high-sensitivity hs-CRP) determines whether a result informs or misleads. For IVD developers, the CRP immunoassay remains one of the highest-volume diagnostic tests globally, covering applications from point-of-care lateral flow rapid tests to high-throughput CLIA analysers. This guide covers the clinical interpretation of CRP from both angles.
What Is C-Reactive Protein (CRP)?
C-reactive protein (CRP) is a pentameric acute-phase protein synthesised almost exclusively in hepatocytes (liver cells) in response to systemic inflammation. It was first described in 1930 by Tillett and Francis at Rockefeller University, named for its capacity to bind the C-polysaccharide antigen of Streptococcus pneumoniae in a calcium-dependent manner.
Hepatic CRP synthesis is driven primarily by interleukin-6 (IL-6), released from macrophages and adipocytes at sites of inflammation, infection, or tissue damage. IL-1β and TNF-α act as co-stimulators. CRP mRNA levels in hepatocytes can rise 1,000-fold within hours of an inflammatory trigger — making CRP one of the most dynamically responsive biomarkers in clinical use. Serum levels begin rising within 4–6 hours of onset, peak at 36–72 hours, and fall with a half-life of approximately 19 hours once the stimulus resolves. This rapid kinetics makes CRP ideal for monitoring treatment response in bacterial infections.
Biologically, CRP functions as a pattern recognition molecule: it activates the classical complement pathway via C1q binding, opsonises bacteria and apoptotic cells for phagocytosis, and modulates monocyte and neutrophil responses. Whether CRP is merely a marker or a mediator of vascular inflammation — particularly in cardiovascular disease — remains an active area of research.
CRP Normal Range
CRP reference ranges differ depending on the assay type ordered. Using the wrong assay for the clinical question is a common source of interpretive error.
| Assay Type | Detection Range | Normal / Reference Range | Primary Use |
|---|---|---|---|
| Standard CRP | 3–200+ mg/L | <10 mg/L | Infection, inflammation monitoring, post-surgical |
| High-Sensitivity CRP (hs-CRP) | 0.1–10 mg/L | <1.0 mg/L (low CV risk) | Cardiovascular risk stratification |
| Cardiac CRP (= hs-CRP) | 0.1–10 mg/L | 1.0–3.0 mg/L (intermediate CV risk) | Same as hs-CRP — different commercial name |
| Neonatal CRP | 1–100 mg/L | <10 mg/L at 48 h of life | Early-onset neonatal sepsis screening |
Key distinction: Standard CRP and hs-CRP measure the same protein. Ordering standard CRP for cardiovascular risk assessment will report values in the 1–3 mg/L range as "normal" or below detection — missing the clinical signal. Always order hs-CRP for cardiac risk evaluation.
What Does High CRP Mean?
Elevated c-reactive protein (CRP >10 mg/L on standard assay) signals active systemic inflammation but does not identify its source. The magnitude of CRP elevation provides diagnostic clues:
CRP Level Interpretation Guide
| CRP Level | Typical Causes |
|---|---|
| 10–40 mg/L | Viral infection, mild bacterial infection, autoimmune flare (early), post-exercise |
| 40–100 mg/L | Active bacterial infection, significant autoimmune flare (RA, IBD), post-operative day 1–2 |
| 100–200 mg/L | Severe bacterial infection, sepsis, major tissue injury, acute pancreatitis |
| >200 mg/L | Severe bacterial sepsis, burns, major surgery, acute MI with large infarct |
CRP in Bacterial vs Viral Infections
One of CRP's most clinically useful features is its differential response to bacterial versus viral infection. Bacterial infections typically drive CRP above 40–50 mg/L within 24–48 hours, while viral infections — including influenza, COVID-19 in mild-moderate cases, and common respiratory viruses — typically produce CRP below 20–30 mg/L. This distinction supports antibiotic stewardship: a CRP below 20 mg/L in a febrile patient with a respiratory illness has a negative predictive value of >90% for bacterial pneumonia (Source: Müller et al., Chest 2007).
Notable exception: Systemic lupus erythematosus (SLE) characteristically produces low CRP elevation even during significant flares — CRP >60 mg/L in an SLE patient should raise suspicion for concurrent bacterial infection rather than pure disease activity.
High-Sensitivity CRP (hs-CRP) and Cardiovascular Risk
The discovery that even low-grade chronic inflammation contributes to atherosclerosis and cardiovascular events transformed CRP from an infection marker into a cardiovascular risk predictor. The landmark JUPITER trial (Ridker et al., NEJM 2008) demonstrated that statin therapy reduced cardiovascular events in patients with elevated hs-CRP (>2 mg/L) but normal LDL cholesterol — establishing hs-CRP as an actionable risk marker beyond the standard lipid panel. (Source: Ridker et al., NEJM 2008)
The American Heart Association and CDC jointly recommend hs-CRP as a secondary cardiovascular risk assessment tool for patients with an intermediate 10-year Framingham Risk Score (10–20%), where it can reclassify patients to higher or lower risk categories and influence treatment decisions.
| hs-CRP Level (mg/L) | Cardiovascular Risk Category | Clinical Action |
|---|---|---|
| <1.0 | Low | No additional intervention indicated |
| 1.0–3.0 | Intermediate | Lifestyle optimisation; consider statin if other risk factors present |
| >3.0 | High | Evaluate for occult infection/inflammation first; if persistent, intensify cardiovascular risk management |
| >10 | Not interpretable for CV risk | Acute inflammation present — repeat after illness resolves |
Important: An hs-CRP >10 mg/L cannot be used for cardiovascular risk stratification — it indicates acute inflammation that will falsely elevate the result. Retest hs-CRP at least 2 weeks after any acute illness, surgery, or injury.
CRP in Specific Clinical Conditions
Rheumatoid Arthritis (RA)
CRP is a core monitoring parameter in RA alongside ESR and DAS28 disease activity scores. CRP >20 mg/L in active RA correlates with joint destruction risk and guides escalation of DMARD or biologic therapy. Persistently elevated CRP despite treatment indicates inadequate disease control. RA typically produces moderate elevations (20–80 mg/L during flares) rather than the very high levels seen in bacterial infection.
Neonatal Sepsis
CRP is a key biomarker for early-onset neonatal sepsis (EONS) screening. CRP <10 mg/L at 24–48 hours of life has a high negative predictive value for bacterial sepsis when combined with clinical assessment. Serial CRP measurements (at 24 h and 48 h) improve sensitivity: two consecutive values below 10 mg/L effectively rules out bacterial sepsis in most cases. Neonatal CRP assays require high precision at low concentrations and short turnaround time for NICU clinical workflow.
Appendicitis
CRP combined with white blood cell count and neutrophil percentage improves appendicitis diagnosis. CRP <10 mg/L within 12 hours of symptom onset has a high negative predictive value; CRP >80 mg/L in a patient with >24 hours of symptoms is highly predictive of perforated appendicitis. The Alvarado score and Appendicitis Inflammatory Response (AIR) score both incorporate CRP.
Post-Surgical Monitoring
CRP rises predictably after major surgery — peaking at day 2–3 and falling by day 5–7 in uncomplicated recovery. A CRP that fails to decline — or rises again — after post-operative day 4 is an early signal of surgical site infection, anastomotic leak, or other complication, often preceding clinical signs by 24–48 hours.
How to Lower High CRP
Reducing elevated CRP requires targeting the underlying inflammatory mechanism. The approach differs depending on whether elevation is acute or chronic.
Treat the Underlying Cause
Antibiotic treatment for bacterial infection brings CRP down within 48–72 hours in responding patients — failure to decrease by 50% within 72 hours of antibiotics suggests treatment failure, resistant organism, or an undrained abscess. Anti-inflammatory therapy (NSAIDs, corticosteroids) reduces CRP within 24–48 hours in autoimmune conditions. DMARDs and biologics (anti-TNF, anti-IL-6) reduce CRP over weeks to months in RA and IBD.
Lifestyle Modification for Chronic Low-Grade Elevation
In patients with chronically elevated hs-CRP (3–10 mg/L) driven by metabolic syndrome or obesity:
- Weight loss: A 5–10% reduction in body weight reduces hs-CRP by 20–40%
- Aerobic exercise: 150 minutes per week of moderate-intensity exercise reduces hs-CRP by 15–25% over 3–6 months
- Mediterranean diet: Rich in omega-3 fatty acids, polyphenols, and fibre; associated with hs-CRP reductions of 20–30%
- Smoking cessation: Smoking elevates hs-CRP by ~50%; cessation normalises levels within 3–6 months
- Statins: Reduce hs-CRP independently of LDL reduction — rosuvastatin in the JUPITER trial reduced hs-CRP by 37% at 12 months
For a comprehensive view of how CRP compares to ESR, procalcitonin, and other acute-phase reactants, see our guide to CRP compared to ESR and other inflammatory markers.
Looking for CRP Antibody for IVD Manufacturing?
Sekbio supplies anti-CRP monoclonal antibody pairs for lateral flow, ELISA, and CLIA platforms — ISO 13485 certified, lot-to-lot CV <8%, validated across the full clinical CRP range (1–300 mg/L).
Frequently Asked Questions About CRP
What is CRP (c-reactive protein)?
CRP (c-reactive protein) is an acute-phase protein produced by the liver in response to inflammation, infection, or tissue injury. It is named for its ability to bind the C-polysaccharide of Streptococcus pneumoniae. CRP is one of the fastest-rising inflammatory markers: levels begin rising within 4–6 hours of an inflammatory stimulus and can increase up to 1,000-fold within 24–72 hours of severe infection.
Its biological role includes complement activation, opsonisation of bacteria, and modulation of innate immune responses. In clinical practice, CRP is used as a non-specific marker of inflammation and infection, and in its high-sensitivity form (hs-CRP) as a cardiovascular risk predictor.
What is a normal CRP level?
For standard CRP, a normal level is below 10 mg/L in healthy adults. For hs-CRP (used for cardiac risk): <1.0 mg/L = low cardiovascular risk; 1.0–3.0 mg/L = intermediate risk; >3.0 mg/L = high risk (per AHA/CDC joint guidelines).
CRP levels above 100 mg/L suggest bacterial infection or major tissue damage. A mildly elevated CRP (10–40 mg/L) warrants clinical evaluation to distinguish infection, autoimmune activity, or benign causes.
What does high CRP mean?
High c-reactive protein (>10 mg/L) indicates active systemic inflammation but does not identify the cause. The magnitude helps narrow the differential: CRP 10–40 mg/L suggests mild infection or early autoimmune flare; 40–100 mg/L points to bacterial infection or significant autoimmune activity; >100 mg/L indicates severe bacterial sepsis or major tissue injury.
CRP does not distinguish between causes — clinical context, history, and additional tests (blood cultures, CBC, autoimmune panels) are needed to identify the source.
What is hs-CRP and how does it differ from regular CRP?
High-sensitivity CRP (hs-CRP) measures the same protein as standard CRP but uses an assay with a detection limit of ~0.1 mg/L, compared to 3–5 mg/L for conventional CRP. This allows meaningful measurement in the 1–3 mg/L range relevant to cardiovascular risk — values that would be reported as "normal" on a standard CRP assay.
Order hs-CRP for cardiac risk assessment; order standard CRP for monitoring infection or acute inflammation. Using standard CRP for cardiac risk is a common clinical error that will miss the signal.
What causes chronically elevated CRP?
Persistently elevated CRP (>10 mg/L for more than 2–4 weeks) suggests an ongoing inflammatory process. Common causes include: uncontrolled autoimmune disease (RA, IBD, ankylosing spondylitis), chronic infection (TB, chronic hepatitis, HIV), obesity (chronic adipose-driven inflammation, typically 3–15 mg/L), malignancy, uncontrolled diabetes, and chronic kidney disease.
A persistently elevated CRP without obvious cause warrants systematic investigation to exclude occult infection, malignancy, and autoimmune disease.
How can high CRP be lowered?
Reducing CRP requires treating the underlying inflammatory cause. For acute infection: appropriate antibiotics reduce CRP by 50%+ within 72 hours in responding patients. For autoimmune disease: anti-inflammatory and immunomodulatory therapy brings CRP down over days to weeks.
For chronic low-grade elevation driven by metabolic syndrome: weight loss (5–10% body weight reduces hs-CRP 20–40%), aerobic exercise, Mediterranean diet, smoking cessation, and statins all reduce hs-CRP meaningfully over 3–6 months.
Can CRP be elevated without infection or disease?
Yes — obesity, vigorous exercise (acute transient rise peaking 24–48 h post-exercise), smoking, poor sleep, high psychological stress, and oral contraceptive pill use (hepatic oestrogen effect) all raise CRP mildly without underlying disease. Pregnancy also raises CRP progressively through the third trimester.
A mildly elevated CRP (3–10 mg/L) in an otherwise well patient often reflects these background factors. Repeat testing after removing modifiable factors is reasonable before escalating investigation.
Planning cardiovascular risk panels? See our guide to other cardiovascular markers including D-dimer for thrombotic risk assessment.